Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Abbott Laboratories : Trump Tests Negative for Covid-19 on Consecutive Days, White House Physician Says -- Update

10/12/2020 | 04:22pm EST

By Alex Leary

President Trump tested negative for Covid-19 on consecutive days, White House physician Sean Conley said in a memo released Monday afternoon as Mr. Trump traveled to Florida for his first formal campaign rally since being treated for the virus.

Dr. Conley said tests and other measurements "have informed our medical team's assessment that the president is not infectious to others."

The memo didn't specify when Mr. Trump was tested.

Mr. Trump was tested using Abbott Laboratories's BinaxNOW Covid-19 Ag Card, the memo said. The U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response Covid-19 antigen test that is roughly the size of a credit card.

"It is important to note that this test was not used in isolation for the determination of the president's current negative status," the doctor's memo said, adding that other data were used. "This comprehensive data, in concert with the CDC's guidelines for removal of transmission-based precautions," informed the team's assessment, the memo said.

The White House has faced pressure to say more about Mr. Trump's testing, and it has declined to say when the president last tested negative before disclosing his positive result around 1 a.m. on Oct. 2, only days after his first debate with Democratic presidential nominee Joe Biden.

Write to Alex Leary at alex.leary@wsj.com

(END) Dow Jones Newswires

10-12-20 1822ET

All news about ABBOTT LABORATORIES
11/20ABBOTT LABORATORIES : Change in Directors or Principal Officers (form 8-K)
AQ
11/19ABBOTT LABORATORIES : Becomes first anchor sponsor of american diabetes associat..
AQ
11/18ABBOTT LABORATORIES : Launches the first infant formula in canada with an ingred..
AQ
11/17ABBOTT LABORATORIES : Launches the First Infant Formula in Canada with an Ingred..
AQ
11/17ABBOTT LABORATORIES : Named industry sustainability leader for the eighth year i..
AQ
11/16HHS Official Says The Agency Has Responded To Every State That Has Requested ..
RE
11/16ABBOTT : Named Industry Sustainability Leader for the Eighth Year in a Row on th..
PR
11/12ABBOTT LABORATORIES : Entry into a Material Definitive Agreement, Termination of..
AQ
11/12ABBVIE : Vice Chairman, Chief Commercial Officer Carlos Alban to Retire
DJ
11/11ABBOTT LABORATORIES : Announces the u.s. launch of the ionicrf generator for use..
AQ
More news
Financials (USD)
Sales 2020 33 873 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 43,9x
Yield 2020 1,34%
Capitalization 191 B 191 B -
EV / Sales 2020 5,98x
EV / Sales 2021 5,20x
Nbr of Employees 107 000
Free-Float 88,9%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 118,44 $
Last Close Price 107,62 $
Spread / Highest target 20,8%
Spread / Average Target 10,1%
Spread / Lowest Target -23,8%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES23.90%190 742
ALIGN TECHNOLOGY, INC.70.41%37 493
SARTORIUS STEDIM BIOTECH98.78%32 358
SYSMEX CORPORATION40.76%21 519
AMERISOURCEBERGEN CORPORATION21.28%21 079
BIO-RAD LABORATORIES, INC.44.60%15 912